Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
1.
West China Journal of Stomatology ; (6): 493-500, 2021.
Artículo en Inglés | WPRIM | ID: wpr-921365

RESUMEN

YAP/TAZ are wild over-activated in head and neck squamous cell carcinoma (HNSCC) with high potential as a direct therapy target for HNSCC treatments. However, the efforts on the directly targeting-YAP/TAZ therapies over the past decade, have very limited impacts, mainly caused by: 1. There is still none effective and specific YAP/TAZ inhibitor with clinical potential; 2. YAP/TAZ might not be directly targeted, because of their multiple important biological functions, such as: regulation of cell proliferation and survival, stem cell maintain, regulation of organ development, organ size control, and tissue regeneration. Interestingly, the over-activation of YAP/TAZ in HNSCC mainly be regulated by upstream abnormal molecular or biological events, instead of genes alteration of YAP/TAZ. Therefore, exploring the alternative molecular events regulating YAP/TAZ activation and molecular mechanism in HNSCC might help to uncover novel indirect targets of YAP/TAZ therapies for HNSCC prevention and treatment.


Asunto(s)
Humanos , Proteínas Adaptadoras Transductoras de Señales/metabolismo , Neoplasias de Cabeza y Cuello , Fosfoproteínas/metabolismo , Transactivadores/metabolismo , Factores de Transcripción
2.
Rev. Soc. Bras. Med. Trop ; 48(1): 44-49, jan-feb/2015. tab
Artículo en Inglés | LILACS | ID: lil-742974

RESUMEN

INTRODUCTION: In 2010, to reduce the occurrence of serious pneumococcal disease, the Ministry of Health in Brazil incorporated the 10-valent pneumococcal vaccine in the immunization schedule of children younger than two years of age. The objective of this study was to evaluate the impact of vaccination on the incidence of infectious respiratory diseases in infants before and after the introduction of the 10-valent pneumococcal vaccine. METHODS: This cross-sectional study involved primary care and hospital networks from a city in Minas Gerais State, Brazil, between 2009 and 2012. RESULTS: A 40% reduction in the prevalence of community-acquired pneumonia (CAP) was observed after introducing the pneumococcal conjugate vaccine. Male children were 28% more likely to develop the disease. The prevalence ratio ([PR] = 1.96, 95% CI: 1.52 to 2.53, p < 0.05) suggested that not being vaccinated was associated with the occurrence of pneumonia. The prevalence of CAP was 70% lower (PR 0.30, 95% CI: 0.24 to 0.37, p<0.05) in children vaccinated as recommended compared to children with delayed vaccination, suggesting that the updated vaccine schedule improves protection. CONCLUSIONS: Immunization with the 10-valent pneumococcal vaccine appeared to reduce the number of pneumonia cases in children during the study period. Prospective studies are needed to confirm the efficacy of the vaccine against the occurrence of pneumococcal pneumonia. .


Asunto(s)
Humanos , VIH-1 , ARN Mensajero/metabolismo , ARN Viral/metabolismo , Proteínas de Unión al ARN/metabolismo , Empalme Alternativo , Western Blotting , Endorribonucleasas/genética , Endorribonucleasas/metabolismo , Exorribonucleasas/genética , Exorribonucleasas/metabolismo , VIH-1 , Interacciones Huésped-Patógeno , Inmunoprecipitación , Unión Proteica , Interferencia de ARN , ARN Mensajero/genética , ARN Viral/genética , Proteínas de Unión al ARN/genética , Transactivadores/genética , Transactivadores/metabolismo
3.
J. bras. nefrol ; 36(4): 496-501, Oct-Dec/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-731149

RESUMEN

Introduction: Polyphenols contained in natural sources such as grapes, have been considered pharmacological agents to combat oxidative stress and inflammation, common features in Chronic Kidney Disease patients. Objective: To evaluate the effects of grape powder supplementation on inflammatory and antioxidant biomarkers in hemodialysis (HD) patients. Methods: The double-blind placebo-controlled randomized clinical trial evaluated non-diabetic HD patients that received grape powder (500 mg of polyphenols/day) (n = 16, 9 men, 53.0 ± 9.8 years of age, 111.6 ± 58.2 HD months) or placebo (n = 16, 9 men, 52.7 ± 13.7 years of age, 110.4 ± 93.1 HD months) for five weeks. The glutathione peroxidase (GSH-Px) activity and C-reactive protein (CRP) levels were evaluated by ELISA method. Results: After the intervention period, the patients receiving grape powder showed an increase in the GSH-Px activity (16.5 (41.0) to 42.0 (43.3) nmol/min/ml) (p < 0.05) and they did not have the CRP levels increased as seen in placebo group (2.6 (0.28) to 2.8 (0.23 mg/L) (p < 0.05). Conclusion: The use of grape powder as phenolic source could play an important role as an antioxidant and anti-inflammatory agent in non-diabetic HD patients. .


Introdução: Polifenóis contidos em fontes naturais, como as uvas, têm sido considerados agentes farmacológicos no combate ao estresse oxidativo e inflamação, condições comuns na Doença Renal Crônica. Objetivo: Avaliar os efeitos da suplementação de farinha de uva sobre marcadores inflamatórios e antioxidantes em pacientes submetidos à hemodiálise (HD). Métodos: Estudo randomizado, duplo-cego, placebocontrolado, no qual foram avaliados pacientes não diabéticos em HD que receberam farinha de uva (500 mg de polifenóis/dia) (n = 16, 9 homens, 53,0 ± 9,8 anos, 111,6 ± 58,2 meses em HD) ou placebo (n = 16, 9 homens, 52,7 ± 13,7 anos, 110,4 ± 93,1 meses em HD) por cinco semanas. A atividade da glutationa peroxidase (GSH-Px) e os níveis plasmáticos de proteína C-reativa (PCR) foram mensurados por meio do método ELISA. Resultados: Após o período de intervenção, os pacientes que receberam farinha de uva apresentaram elevação na atividade da GSH-Px (16,5 (41,0) para 42,0 (43,3) nmol/min/ml) (p < 0,05) e não foi observada elevação nos níveis de PCR, como visto no grupo placebo (2,6 (0,28) para 2,8 (0,23) mg/L) (p < 0,05). Conclusão: O uso da farinha de uva como fonte de polifenóis pode desempenhar um importante papel anti-inflamatório e antioxidante em pacientes não diabéticos submetidos à HD. .


Asunto(s)
Humanos , Proteínas de Unión al ADN , Regulación de la Expresión Génica , Mutación , Proteínas Nucleares , Transactivadores/metabolismo , Factores de Transcripción/metabolismo , Sitios de Unión , Carcinoma Hepatocelular , ADN Viral/metabolismo , Factor Nuclear 1 del Hepatocito , Factor Nuclear 1-alfa del Hepatocito , Factor Nuclear 1-beta del Hepatocito , Virus de la Hepatitis B/genética , Virus de la Hepatitis B/metabolismo , Pruebas de Precipitina , Plásmidos/genética , Precursores de Proteínas/genética , Precursores de Proteínas/metabolismo , Transfección , Células Tumorales Cultivadas , Transactivadores/genética , Factores de Transcripción/genética , Proteínas del Núcleo Viral/genética , Proteínas del Núcleo Viral/metabolismo
4.
Braz. j. infect. dis ; 17(2): 125-130, Mar.-Apr. 2013. ilus, tab
Artículo en Inglés | LILACS | ID: lil-673188

RESUMEN

Several studies have been conducted in recent years to elucidate the structure, function and significance of AcrB, MarA, SoxS and RamA in Salmonella enterica. In this study, the relative quantification of acrB, soxS, marA and ramA genes expression was evaluated in 14 strains of S. enterica, with or without accompanying mutations in the quinolone resistance-determining regions of the gyrA gene, that were exposed to ciprofloxacin during the exponential growth phase. The presence of ciprofloxacin during the log phase of bacterial growth activated the genes marA, soxS, ramA and acrB in all S. enterica strains analyzed in this study. The highest expression levels for acrB were observed in strains with gyrA mutation, and marA showed the highest expression in the strains without mutation. Considering only the strains with ciprofloxacin minimum inhibitory concentration values < 0.125 [1]g/mL (sensitive to ciprofloxacin), the most expressed gene in the strains both with and without mutations was acrB. In the strains with ciprofloxacin minimum inhibitory concentration values > 0.125 [1]g/mL (low susceptibility), with and without mutations in gyrA, the most expressed gene was marA. In this study, we observed that strains resistant to nalidixic acid may express genes associated with the efflux pump and the expression of the AcrAB-TolC pump genes seems to occur independently of mutations in gyrA.


Asunto(s)
Humanos , Proteínas Bacterianas/genética , Farmacorresistencia Bacteriana/genética , Mutación/genética , Salmonella enterica/efectos de los fármacos , Salmonella enterica/genética , Antibacterianos/farmacología , Proteínas Bacterianas/metabolismo , Ciprofloxacina/farmacología , Regulación Bacteriana de la Expresión Génica , Genes Bacterianos/genética , Pruebas de Sensibilidad Microbiana , Proteínas de Transporte de Membrana/genética , Proteínas de Transporte de Membrana/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , ARN Bacteriano/genética , Transactivadores/genética , Transactivadores/metabolismo
5.
Experimental & Molecular Medicine ; : 26-35, 2012.
Artículo en Inglés | WPRIM | ID: wpr-211721

RESUMEN

Recent evidence has suggested that human skin fibroblasts may represent a novel source of therapeutic stem cells. In this study, we report a 3-stage method to induce the differentiation of skin fibroblasts into insulin-producing cells (IPCs). In stage 1, we establish the isolation, expansion and characterization of mesenchymal stem cells from human labia minora dermis-derived fibroblasts (hLMDFs) (stage 1: MSC expansion). hLMDFs express the typical mesenchymal stem cell marker proteins and can differentiate into adipocytes, osteoblasts, chondrocytes or muscle cells. In stage 2, DMEM/F12 serum-free medium with ITS mix (insulin, transferrin, and selenite) is used to induce differentiation of hLMDFs into endoderm-like cells, as determined by the expression of the endoderm markers Sox17, Foxa2, and PDX1 (stage 2: mesenchymal-endoderm transition). In stage 3, cells in the mesenchymal-endoderm transition stage are treated with nicotinamide in order to further differentiate into self-assembled, 3-dimensional islet cell-like clusters that express multiple genes related to pancreatic beta-cell development and function (stage 3: IPC). We also found that the transplantation of IPCs can normalize blood glucose levels and rescue glucose homeostasis in streptozotocin-induced diabetic mice. These results indicate that hLMDFs have the capacity to differentiate into functionally competent IPCs and represent a potential cell-based treatment for diabetes mellitus.


Asunto(s)
Animales , Femenino , Humanos , Ratones , Biomarcadores/metabolismo , Técnicas de Cultivo de Célula , Diferenciación Celular , Proliferación Celular/efectos de los fármacos , Separación Celular , Células Cultivadas , Dermis/citología , Diabetes Mellitus Experimental/cirugía , Fibroblastos/citología , Genitales Femeninos/citología , Glucosa/metabolismo , Factor Nuclear 3-beta del Hepatocito/metabolismo , Proteínas de Homeodominio/metabolismo , Insulina/farmacología , Células Secretoras de Insulina/citología , Trasplante de Islotes Pancreáticos , Células Madre Mesenquimatosas/citología , Ratones Desnudos , Niacinamida/farmacología , Recuperación de la Función , Factores de Transcripción SOXF/metabolismo , Selenito de Sodio/farmacología , Transactivadores/metabolismo , Transferrina/farmacología
6.
Journal of Korean Medical Science ; : 214-221, 2011.
Artículo en Inglés | WPRIM | ID: wpr-123288

RESUMEN

Hepatitis B virus X (HBx) protein has been known to play an important role in development of hepatocellular carcinoma (HCC). The aim of this study is to find out whether HBx protein expression affects antiproliferative effect of an epidermal growth factor receptor-tyrosine kinase (EGFR-TK) inhibitor and a MEK inhibitor in HepG2 and Huh-7 cell lines. We established HepG2 and Huh-7 cells transfected stably with HBx gene. HBx protein expression increased pERK and pAkt expression as well as beta-catenin activity in both cells. Gefitinib (EGFR-TK inhibitor) inhibited pERK and pAkt expression and beta-catenin activity in both cells. Selumetinib (MEK inhibitor) reduced pERK level and beta-catenin activity but pAkt expression was rather elevated by selumetinib in these cells. Reduction of pERK levels was much stronger with selumetinib than gefitinib in both cells. The antiproliferative efficacy of selumetinib was more potent than that of gefitinib. However, the antiproliferative effect of gefitinib, as well as selumetinib, was not different between cell lines with or without HBx expression. Signal pathway activation by HBx might not be strong enough to attenuate the antiproliferative effect of EGFR-TK inhibitor. Future experiments are needed to understand the role of HBx protein expression in HCC treatment using molecular targeting agent.


Asunto(s)
Animales , Humanos , Antineoplásicos/farmacología , Bencimidazoles/farmacología , Carcinoma Hepatocelular/metabolismo , Línea Celular Tumoral/efectos de los fármacos , Proliferación Celular , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Neoplasias Hepáticas/metabolismo , Quinasas de Proteína Quinasa Activadas por Mitógenos/antagonistas & inhibidores , Inhibidores de Proteínas Quinasas/farmacología , Proteínas Proto-Oncogénicas c-akt , Quinazolinas/farmacología , Receptores ErbB/antagonistas & inhibidores , Transducción de Señal/efectos de los fármacos , Transactivadores/metabolismo , beta Catenina/metabolismo
7.
Indian J Biochem Biophys ; 2010 Oct; 47(5): 272-277
Artículo en Inglés | IMSEAR | ID: sea-135276

RESUMEN

The peroxisome proliferator-activated receptor (PPAR) gamma co-activator 1 alpha (PGC-1 ), a signal-sensing transcriptional co-activator in association with many nuclear receptors regulates various genes that control energy balance in animals. In this study, the effect of long-term caloric restriction (CR) (alternate days of fasting for 3 months) on the expression of PGC-1 protein in various tissues was investigated in mice. Western blot analyses showed positive immunoreactive PGC-1 (~92 kDa) signal from various tissues. Heart, kidney and skeletal muscles expressed significant levels of PGC-1 , while a comparatively lower level was detected in the liver, small intestine and brain. The expression of PGC-1 was the highest and lowest in the heart and liver respectively. CR mice exhibited a significant increase in PGC-1a level in the heart (5.13-fold), kidney (3.57-fold), skeletal muscle (3.02-fold), liver (2.60-fold), small intestine (2.45-fold) and brain (2.05-fold), compared to normal (ad libitum) fed. The elevation in PGC-1 level, especially in highly oxidative tissues such as heart, kidney and skeletal muscle of CR mice might synergistically up-regulate genes that require PGC-1 co-activation. Taken together, the up-regulation of PGC-1 expression might potentially support optimal energy metabolism and biochemical adaptation, necessary for maintaining energy homeostasis during long-term CR.


Asunto(s)
Animales , Restricción Calórica/métodos , Ingestión de Alimentos/fisiología , Masculino , Tasa de Depuración Metabólica , Ratones , Ratones Endogámicos BALB C , Especificidad de Órganos/fisiología , Distribución Tisular , Transactivadores/metabolismo , Regulación hacia Arriba/fisiología
8.
The Korean Journal of Hepatology ; : 112-122, 2010.
Artículo en Coreano | WPRIM | ID: wpr-14489

RESUMEN

Infection of hepatitis B virus (HBV) is a main cause of liver diseases including hepatitis, cirrhosis and hepatocellular carcinoma (HCC). Among the HBV-encoded proteins, the HBV X protein (HBx) has been suspected to be strongly involved in HBV-associated liver pathogenesis. HBx, a virally encoded multifunctional regulator, has been shown to induce apoptosis, anti-apoptosis, proliferation, and transformation of cells depending on the cell lines, model systems used, assay protocols, and research groups. Among the several activities of HBx, the pro-apoptotic function of HBx will be discussed in this review. Given that the disruption of apoptosis pathway by HBx contributes to the liver pathogenesis, a better understanding of the molecular interference in the cellular pro-apoptotic networks by HBx will provide useful clues for the intervention in HBV-mediated liver diseases.


Asunto(s)
Apoptosis , Hepatitis B/etiología , Hepatopatías/metabolismo , Transactivadores/metabolismo , Factores de Necrosis Tumoral/metabolismo , Proteína p53 Supresora de Tumor/metabolismo
9.
Experimental & Molecular Medicine ; : 880-895, 2009.
Artículo en Inglés | WPRIM | ID: wpr-202558

RESUMEN

We sought to determine the effects of activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on multilocularization of adipocytes in adult white adipose tissue (WAT). Male C57BL/6 normal, db/db, and ob/ob mice were treated with agonists of PPAR-gamma, PPAR-alpha, or beta3-adrenoceptor for 3 weeks. To distinguish multilocular adipocytes from unilocular adipocytes, whole-mounted adipose tissues were co-immunostained for perilipin and collagen IV. PPAR-gamma activation with rosiglitazone or pioglitazone induced a profound change of unilocular adipocytes into smaller, multilocular adipocytes in adult WAT in a time-dependent, dose-dependent, and reversible manner. PPAR-alpha activation with fenofibrate did not affect the number of locules or remodeling. db/db and ob/ob obese mice exhibited less multilocularization in response to PPAR-gamma activation compared to normal mice. Nevertheless, all adipocytes activated by PPAR-gamma contained a single nucleus regardless of locule number. Multilocular adipocytes induced by PPAR-gamma activation contained substantially increased mitochondrial content and enhanced expression of uncoupling protein-1, PPAR-gamma coactivator-1-alpha , and perilipin. Taken together, PPAR-gamma activation induces profound multilocularization and enhanced mitochondrial biogenesis in the adipocytes of adult WAT. These changes may affect the overall function of WAT.


Asunto(s)
Animales , Masculino , Ratones , Adipocitos/citología , Tejido Adiposo Blanco/citología , División del Núcleo Celular , Hipoglucemiantes/farmacología , Canales Iónicos/metabolismo , Ratones Endogámicos C57BL , Ratones Obesos , Mitocondrias/metabolismo , Proteínas Mitocondriales/metabolismo , PPAR alfa/agonistas , PPAR gamma/agonistas , Fosfoproteínas/metabolismo , Receptores Adrenérgicos beta 3/agonistas , Tiazolidinedionas/farmacología , Transactivadores/metabolismo
10.
Journal of Korean Medical Science ; : 864-869, 2008.
Artículo en Inglés | WPRIM | ID: wpr-37029

RESUMEN

To compare the stem niche in different culture conditions of limbal epithelial cells, the suspended human limbal epithelial cells (HLECs) were seeded on the 3T3-pretreated plates and the other suspended cells were plated on amniotic membranes (AMs) which were either cryo-preserved or freeze-dried. All were cultured for 10 to 12 days. Reverse transcription-polymerase chain reaction (RT-PCR) for ATP-binding casette, subfamily G, member 2 (ABCG2), p63, cytokeratin 12, and connexin 43 were performed in cultivated HLECs and their expression levels were compared. The mRNA expression of all markers examined showed no statistically significant differences between the cells on cryo-preserved and on freeze-dried AM. The expression of p63 and cytokeratin 12 in cultivated cells on AMs were significantly lower than those in 3T3-cocultured cells on RT-PCR and immunofluorescent staining. Cultivated HLECs on AMs showed reduced proliferation and differentiation while maintaining stem-property regardless of the preservative method of AM.


Asunto(s)
Animales , Humanos , Ratones , Células 3T3 , Técnicas de Cultivo de Célula/instrumentación , Células Cultivadas , Técnicas Citológicas , Cartilla de ADN/química , Células Epiteliales/metabolismo , Inmunohistoquímica/métodos , Queratina-12/metabolismo , Modelos Biológicos , Fosfoproteínas/metabolismo , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Células Madre/citología , Transactivadores/metabolismo
11.
Arq. bras. endocrinol. metab ; 51(5): 683-689, jul. 2007. ilus
Artículo en Portugués | LILACS | ID: lil-461316

RESUMEN

TGFbeta e activina são membros da superfamília TGFbeta e desempenham um amplo papel no desenvolvimento, proliferação e apoptose. Estes fatores de crescimento exercem seus efeitos biológicos ligando-se a receptores de membrana do tipo I e do tipo II que transduzem a sinalização até o núcleo através da fosforilação das proteínas R-SMADs (SMAD 2/3) e co-SMADs (SMAD4). O controle apropriado da via de TGFbeta/activina ainda depende da regulação negativa exercida pelo SMAD inibitório (SMAD7) e pelas enzimas E3 de ubiquitinação (Smurfs). Fisiologicamente, TGFbeta e activina atuam como potentes inibidores da proliferação na célula folicular tiroidiana. Desta forma, alterações de receptores e componentes da via de sinalização SMAD estão associadas a diferentes tipos de tumores. Desde que TGFbeta e activina geram sua sinalização intracelular utilizando os mesmos componentes da via SMAD, o desequilíbrio desta via prejudica dois processos anti-mitogênicos da célula. Nesta revisão, enfocamos aspectos que indicam o mecanismo de resistência ao efeito inibitório de TGFbeta e activina ocasionado pelo desequilíbrio da via de sinalização SMAD nas neoplasias da tiróide.


TGFbeta and activin are members of the TGFbeta superfamily and play a wide role in development, proliferation and apoptosis. These growth factors exert their biological effects by binding to the type I and II membrane receptors to transduce their signalling through the nucleus by phosphorylation of R-SMADs (SMAD 2/3) and co-SMADs (Smad 4). The proper control of TGFbeta/activin pathway is negatively regulated by inhibitory SMAD (SMAD7) and by E3 ubiquitination enzymes (Smurfs). Physiologically, TGFbeta and activin act as potent growth inhibitors in thyroid follicular cell. Thus, alterations in the receptors and components of SMAD signalling pathway are associated with several types of tumors. Since TGFbeta and activin generate their intracellular signalling through the same components of the SMAD pathway, the unbalance of this pathway impairs both of anti-mitogenic signals in the cell. This review addresses aspects of the molecular mechanisms in the understanding of resistance to the growth inhibitory effects of TGFbeta and activin due to the disequilibrium in the SMAD inhibitory pathway in thyroid neoplasia.


Asunto(s)
Humanos , Activinas/metabolismo , Transducción de Señal/fisiología , Proteínas Smad/metabolismo , Neoplasias de la Tiroides/metabolismo , Transactivadores/metabolismo , Factor de Crecimiento Transformador beta/metabolismo , Línea Celular , Proteínas de Unión al ADN/metabolismo , Regulación de la Expresión Génica , Proteínas Quinasas Activadas por Mitógenos/genética , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Fosforilación , Receptores de Factores de Crecimiento/genética , Receptores de Factores de Crecimiento/metabolismo , Transcripción Genética , Neoplasias de la Tiroides/genética , Transactivadores/genética , Ubiquitina-Proteína Ligasas
12.
Journal of Huazhong University of Science and Technology (Medical Sciences) ; (6): 639-42, 2007.
Artículo en Inglés | WPRIM | ID: wpr-635007

RESUMEN

Pdx-1, an important transcription factor highlighting in the early pancreatic development, islet functions and pancreatic disorders, needs to be more investigated in zebrafish, and siRNA is still seldom applied in zebrafish embryo-related research. Our aim was to explore the role of pdx-1 in pancreatic development of zebrafish embryos by using siRNA approach. Microinjection, reverse transcriptase-PCR (RT-PCR), in situ hybridization and immunofluorescent staining were used in this research, and the morphology of the islet in normal zebrafish embryos, and in those treated with the siRNA specific to pdx-1 (siPDX-1) or siGFP was observed and compared. The expression of pdx-1 was detected in the stages of 1-cell, 2-cell, 4-cell, 8-cell, 16-cell, 16-hour by RT-PCT. The in situ hybridization and immunofluorescent staining results showed that siPDX-1 disturbed the formation of the islet in zebrafish embryos. Pdx-1 played multiple roles in maintaining the phenotype of the islet during embryogenesis in zebrafish.


Asunto(s)
Embrión no Mamífero , Proteínas de Homeodominio/genética , Proteínas de Homeodominio/metabolismo , Islotes Pancreáticos/citología , Islotes Pancreáticos/embriología , Islotes Pancreáticos/metabolismo , Interferencia de ARN , ARN Interferente Pequeño/genética , Transactivadores/genética , Transactivadores/metabolismo , Pez Cebra
13.
The Korean Journal of Hepatology ; : 320-340, 2007.
Artículo en Coreano | WPRIM | ID: wpr-7448

RESUMEN

Hepatocellular carcinoma (HCC) is one of the most common malignant diseases in the world. The hepatitis B virus (HBV) replicates non-cytopathically in hepatocytes, and most of the liver injury associated with this infection reflects the immune response. Epidemiological studies have clearly demonstrated that a chronic HBV infection is a major etiological factor in the development of HCC. The pathogenesis of HBV-associated HCC has been studied extensively, and the molecular changes during the malignant transformation have been identified. The main carcinogenic mechanism of HBV-associated HCC is related to the long term-inflammatory changes caused by a chronic hepatitis B infection, which might involve the integration of the HBV. Integration of the HBV DNA into the host genome occurs at the early steps of clonal tumorous expansion. The hepatitis B x protein (HBx) is a multifunctional regulatory protein that communicates directly or indirectly with a variety of host targets, and mediates many opposing cellular functions, including its function in cell cycle regulation, transcriptional regulation, signaling, encoding of the cytoskeleton and cell adhesion molecules, as well as oncogenes and tumor suppressor genes. Continued study of the mechanisms of hepatocarcinogenesis will refine our current understanding of the molecular and cellular basis for neoplastic transformations in the liver. This review summarizes the current knowledge of the mechanisms involved in HBV-associated hepatocarcinogenesis.


Asunto(s)
Humanos , Apoptosis/genética , Carcinoma Hepatocelular/patología , Ciclo Celular , Reparación de la Incompatibilidad de ADN , Virus de la Hepatitis B/genética , Hepatitis B Crónica/complicaciones , Neoplasias Hepáticas/patología , Neovascularización Patológica/genética , Telómero/genética , Transactivadores/metabolismo , Transcripción Genética
14.
Indian J Pathol Microbiol ; 2006 Apr; 49(2): 279-81
Artículo en Inglés | IMSEAR | ID: sea-75678

RESUMEN

Myoepithelioma of breast are extremely rare. We report two cases of pure malignant myoepithelioma of the breast, utilising light microscopic and immunohistochemical methods for diagnosis. Both the cases presented as breast lump. Hematoxylin and Eosin (H&E) stained microscopic sections revealed a predominantly spindle cell tumor. Immunohistochemical work up was done. Case number one expressed positivity for vimentin, Smooth Muscle Actin (SMA), S-100 and CD10. Case number two expressed positivity for Vimentin, CD10 and p63. This led to the diagnoses of malignant myoepithelioma in both of them. Documentation of such cases prospectively and from archival material, using immunohistochemistry, is of extreme importance to assess the prevalence, various phenotypic patterns, long-term biological behaviour and to establish management protocols for malignant myoepithelioma.


Asunto(s)
Actinas/metabolismo , Neoplasias de la Mama/diagnóstico , Proteínas de Unión al ADN/metabolismo , Femenino , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Mioepitelioma/diagnóstico , Neprilisina/metabolismo , Proteínas S100/metabolismo , Transactivadores/metabolismo , Proteínas Supresoras de Tumor/metabolismo , Vimentina/metabolismo
15.
Biol. Res ; 39(1): 87-93, 2006. ilus
Artículo en Inglés | LILACS | ID: lil-430701

RESUMEN

Copper is an essential and toxic trace metal for bacteria and, therefore, must be tightly regulated in the cell. Enterococcus hirae is a broadly studied model for copper homeostasis. The intracellular copper levels in E. hirae are regulated by the cop operon, which is formed by four genes: copA and copB that encode ATPases for influx and efflux of copper, respectively; copZ that encodes a copper chaperone; and copY, a copper responsive repressor. Since the complete genome sequence for E. hirae is not available, it is possible that other genes may encode proteins involved in copper homeostasis. Here, we identified a cop-like operon in nine species of Lactobacillale order with a known genome sequence. All of them always encoded a CopY-like repressor and a copper ATPase. The alignment of the cop-like operon promoter region revealed two CopY binding sites, one of which was conserved in all strains, and the second was only present in species of Streptococcus genus and L. johnsonii. Additional proteins associated to copper metabolism, CutC and Cupredoxin, also were detected. This study allowed for the description of the structure and organization of the cop operon and discussion of a phylogenetic hypothesis based on the differences observed in this operon's organization and its regulation in Lactobacillale order.


Asunto(s)
Cobre/metabolismo , Enterococcus/genética , Homeostasis/genética , Operón/genética , Adenosina Trifosfatasas/genética , Adenosina Trifosfatasas/metabolismo , Secuencia de Bases , Sitios de Unión , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Proteínas de Transporte de Catión/genética , Proteínas de Transporte de Catión/metabolismo , Enterococcus/metabolismo , Datos de Secuencia Molecular , Chaperonas Moleculares/genética , Chaperonas Moleculares/metabolismo , Unión Proteica , Proteínas Represoras/genética , Proteínas Represoras/metabolismo , Transactivadores/genética , Transactivadores/metabolismo
16.
Experimental & Molecular Medicine ; : 179-185, 2005.
Artículo en Inglés | WPRIM | ID: wpr-201945

RESUMEN

15-deoxy-delta12,14-PGJ2(15d-PGJ2) is a natural ligand that activates the peroxisome proliferators-activated receptor (PPAR) gamma, a member of nuclear receptor family implicated in regulation of lipid metabolism and adipocyte differentiation. Recent studies have shown that 15d-PGJ2 is the potent anti-inflammatory agent functioning via PPARgamma-dependent and -independent mechanisms. Most postulated mechanisms for anti-inflammatory action of PPARgamma agonists are involved in inhibiting NF-kappaB signaling pathway. We examined the possibility that IL-6 signaling via the Jak-Stat pathway is modulated by 15d-PGJ2 in lymphocytes and also examined whether the inhibition of IL-6 signaling is dependent of PPARgamma. 15d-PGJ2 blocked IL-6 induced Stat1 and Stat3 activation in primary human lymphocytes, Jurkat cells and immortalized rheumatoid arthritis B cells. Inhibition of IL-6 signaling was induced rapidly within 15 min after treatment of 15d-PGJ2. Other PPARgamma-agonists, such as troglitazone and ciglitazone, did not inhibit IL-6 signaling, indicating that 15d-PGJ2 affect the IL-6-induced Jak-Stat signaling pathway via PPARgamma-independent mechanism. Although cycloheximide reversed 15d-PGJ2-mediated inhibition of Stat3 activation, actinomycin D had no effect on 15d-PGJ2-mediated inhibition of IL-6 signaling, indicating that inhibition of IL-6 signaling occur independent of de novo gene expression. These results show that 15d-PGJ2 specifically inhibit Jak-Stat signaling pathway in lymphocytes, and suggest that 15d-PGJ2 may regulate inflammatory reactions through the modulation of different signaling pathway other than NF-kappaB in lymphocytes.


Asunto(s)
Humanos , Artritis Reumatoide/metabolismo , Cromanos/farmacología , Cicloheximida/farmacología , Proteínas de Unión al ADN/metabolismo , Dactinomicina/farmacología , Regulación de la Expresión Génica , Hipoglucemiantes/farmacología , Interleucina-6/farmacología , Células Jurkat/metabolismo , Linfocitos/citología , FN-kappa B/metabolismo , PPAR gamma/metabolismo , Fosforilación , Prostaglandina D2/análogos & derivados , Inhibidores de la Síntesis de la Proteína/farmacología , Transducción de Señal , Tiazolidinedionas/farmacología , Transactivadores/metabolismo
17.
The Korean Journal of Gastroenterology ; : 291-296, 2005.
Artículo en Coreano | WPRIM | ID: wpr-108015

RESUMEN

BACKGROUND/AIMS: Hedgehog protein is an essential molecule for gastrointestinal tract development, and disruption of hedgehog signaling pathway is linked to some gastrointestinal tumorigenesis. Here, we performed hedgehog immunostaining in periampullary cancer to evaluate the differences according to the location type of cancer and the differentiation of adenocarcinoma. METHODS: We retrieved surgical specimens from 43 periampullary cancer patients (15 ampulla of Vater cancer, 12 distal common bile duct cancer, 13 pancreatic head cancer, and 3 combined ampulla of Vater/bile duct cancer). Immunohistochemical stain was performed in both normal and cancerous tissue portions of each case using Sonic hedgehog (H-160) rabbit polyclonal antibody. Immunohistochemical stain results were grouped into three groups according to the percentage of positive cytoplasmic stain in tumor volume (unstained: 50%). RESULTS: All of the normal tissue revealed negative immunohistochemical stain while cancerous tissue revealed positivity in 95.3% (41/43 cases). Strongly stained cases were more frequently seen in ampulla of Vater cancers (13/15) and in combined ampulla of Vater/bile duct cancers (3/3) than in distal common bile duct cancers (4/12) and in pancreatic head cancers (3/13) (p=0.002). In addition, strongly stained cases were more frequently seen in well-differentiated adenocarcinoma than the others (p<0.001). CONCLUSIONS: Most of the periampullary cancers show hedgehog protein expression. In addition, hedgehog protein immunostainings shows stronger expression in ampulla of Vater cancers and in well-differentiated adenocarcinoma.


Asunto(s)
Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Adenocarcinoma/metabolismo , Ampolla Hepatopancreática , Neoplasias del Conducto Colédoco/metabolismo , Resumen en Inglés , Inmunohistoquímica , Neoplasias Pancreáticas/metabolismo , Transactivadores/metabolismo
18.
Braz. j. med. biol. res ; 37(12): 1811-1818, Dec. 2004. ilus, tab
Artículo en Inglés | LILACS | ID: lil-388068

RESUMEN

Activation of NFkappaB plays a pivotal role in many cellular processes such as inflammation, proliferation and apoptosis. In Drosophila, nuclear translocation of the NFkappaB-related transcription factor Dorsal is spatially regulated in order to subdivide the embryo into three primary dorsal-ventral (DV) domains: the ventral presumptive mesoderm, the lateral neuroectoderm and the dorsal ectoderm. Ventral activation of the Toll receptor induces degradation of the IkappaB-related inhibitor Cactus, liberating Dorsal for nuclear translocation. In addition, other pathways have been suggested to regulate Dorsal. Signaling through the maternal BMP member Decapentaplegic (Dpp) inhibits Dorsal translocation along a pathway parallel to and independent of Toll. In the present study, we show for the first time that the maternal JAK/STAT pathway also regulates embryonic DV patterning. Null alleles of loci coding for elements of the JAK/STAT pathway, hopscotch (hop), marelle (mrl) and zimp (zimp), modify zygotic expression along the DV axis. Genetic analysis suggests that the JAK kinase Hop, most similar to vertebrate JAK2, may modify signals downstream of Dpp. In addition, an activated form of Hop results in increased levels of Cactus and Dorsal proteins, modifying the Dorsal/Cactus ratio and consequently DV patterning. These results indicate that different maternal signals mediated by the Toll, BMP and JAK/STAT pathways may converge to regulate NFkappaB activity in Drosophila.


Asunto(s)
Animales , Masculino , Femenino , Embarazo , Tipificación del Cuerpo , Proteínas de Unión al ADN/fisiología , Proteínas de Drosophila/fisiología , Drosophila/embriología , Proteínas Nucleares/fisiología , Proteínas Tirosina Quinasas , Fosfoproteínas/fisiología , Transactivadores/fisiología , Factores de Transcripción/fisiología , Tipificación del Cuerpo/genética , Proteínas de Unión al ADN/genética , Proteínas de Unión al ADN/metabolismo , Proteínas de Drosophila/genética , Proteínas de Drosophila/metabolismo , Drosophila/genética , Electroforesis en Gel de Poliacrilamida , Immunoblotting , FN-kappa B/fisiología , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Proteínas Tirosina Quinasas , Fosfoproteínas/genética , Fosfoproteínas/metabolismo , Transducción de Señal , Transactivadores/genética , Transactivadores/metabolismo , Factores de Transcripción/genética , Factores de Transcripción/metabolismo
19.
Experimental & Molecular Medicine ; : 283-291, 2004.
Artículo en Inglés | WPRIM | ID: wpr-198866

RESUMEN

Met tyrosine kinase receptor, the receptor of hepatocyte growth factor/scatter factor (HGF/SF), is present in mouse tissues as two major isoforms differing by a 47-aminoacid segment in the juxtamembrane domain via alternative splicing of exon 14. We found that the smaller isoform of Met (Sm-Met) was highly transformable in both in vitro and in vivo tumorigenesis assays. In this report, close examination of the transforming activity of the Sm-Met showed that the expression of Sm-Met conferred the cells serum independence and anti- apoptotic property when treated with doxorubicin. These properties of Sm-Met seemed to be originated from its far longer maintenance of tyrosine kinase activity after the binding of HGF/SF. Interestingly, the longer maintenance of activated status was accompanied with more increase of tyrosine phosphorylation of Stat3 protein. Moreover, we have tried to find (an) animal tumorigenesis model(s) showing the increase in the expression of this transforming variant of Met. In gamma-ray-induced mouse thymic lymphoma model, the expression of the mRNAs for Sm-Met was significantly increased as well as those of wild type Met and HGF/SF, suggesting a possible role of the Sm-Met in tumorigenesis in vivo.


Asunto(s)
Animales , Ratones , Apoptosis , Proliferación Celular , Supervivencia Celular , Transformación Celular Neoplásica , Proteínas de Unión al ADN/metabolismo , Doxorrubicina/farmacología , Factor de Crecimiento de Hepatocito/farmacología , Linfoma/etiología , Células 3T3 NIH , Fosforilación , Isoformas de Proteínas/genética , Proteínas Proto-Oncogénicas c-met/genética , ARN Mensajero/análisis , Suero/metabolismo , Timo , Transactivadores/metabolismo
20.
Journal of Veterinary Science ; : 131-137, 2004.
Artículo en Inglés | WPRIM | ID: wpr-128641

RESUMEN

Toxic effects of ozone, 4-(N-methyl-N-nitrosamino)-1-(3- pyridyl)-1-butanone (NNK), and/or dibutyl phthalate (DBP) were examined through NF-kappaB, AP-1, Nrf2, and osteopontin (OPN) in lungs and livers of B6C3F1 mice. Electrophoretic mobility shift assay (EMSA) indicated that mice treated with combination of toxicants induced high NF-kappaB activities. Expression levels of p105, p65, and p50 proteins increased in all treated mice, whereas IkB activity was inhibited in NNK-, DBP-, and combination-treated ones. All treated mice except ozone-treated one showed high AP-1 binding activities. Expression levels of c-fos, c-jun, junB, jun D, Nrf2, and OPN proteins increased in all treated mice. Additive interactions were frequently noted from two-toxicant combination mice compared to ozone-treated one. These results indicate treatment of mixture of toxicants increased toxicity through NF-kappaB, AP-1, Nrf2, and OPN. Our data could be applied to the elucidation of mechanism as well as the risk assessment of mixture-induced toxicity.


Asunto(s)
Animales , Ratones , Western Blotting , Proteínas de Unión al ADN/metabolismo , Dibutil Ftalato/toxicidad , Ensayo de Cambio de Movilidad Electroforética , Riñón/efectos de los fármacos , Hígado/efectos de los fármacos , Ratones Endogámicos , Factor 2 Relacionado con NF-E2 , FN-kappa B/metabolismo , Nitrosaminas/toxicidad , Osteopontina , Ozono/toxicidad , Proteínas Proto-Oncogénicas/metabolismo , Medición de Riesgo , Sialoglicoproteínas/metabolismo , Transactivadores/metabolismo , Factor de Transcripción AP-1/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA